Atlas Venture Associates Opportunity I, L.P., 10% Owner at Xilio Therapeutics, Inc. (XLO), sold 4,235 shares at $0.87 ($4K) on 2024-01-11, disclosed to the SEC on 2024-01-16.
Open-market sale of $4k XLO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.87 | 569 | $495 | 13.7% |
| 2 | $0.87 | 1,566 | $1K | 37.8% |
| 3 | $0.83 | 560 | $465 | 12.9% |
| 4 | $0.83 | 1,540 | $1K | 35.5% |
| Total | $0.85 avg | 4,235 | $4K | 100% |
| Filing → |
| KYMR | SELL | 2022-11-04 | $10.3M | — | Filing → |